foxo4-dri peptide senolytic 2023 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI Peptide Dosing Guide: Senolytic

Food and Drug Administration (FDA) announced that it will convene a public meeting of the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to consider whether to recommend seven (7) peptide bulk drug substances for inclusion on the list of substances that may be used in compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act

If you would like to learn more, you can book a consultation with us to determine whether Semax may be appropriate for your needs

Angiogenesis is the process of new blood vessel formation and it is helpful in wound healing as the newer blood vessels formed at the injured site are important to provide nutrients, immune cells, and oxygen for the healing of wounds

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM